Ligand validation:4NJJ

SAM: S-ADENOSYLMETHIONINE

SAM is a Ligand Of Interest in 4NJJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NJJ_SAM_B_302	78%	55%	0.132	0.976	0.81	0.91	-	1	1	0	100%	1
4NJJ_SAM_A_302	78%	56%	0.132	0.974	0.8	0.88	-	1	0	0	100%	1
4NJK_SAM_A_302	94%	50%	0.08	0.978	0.83	1.09	-	2	0	0	100%	1
4NJH_SAM_A_302	94%	52%	0.079	0.976	0.78	1.07	-	2	0	0	100%	1
4NJI_SAM_B_302	92%	52%	0.084	0.975	0.85	1.01	-	1	0	0	100%	1
4NJG_SAM_B_302	79%	57%	0.127	0.972	0.78	0.89	-	1	0	0	100%	1
2P02_SAM_A_2	100%	41%	0.038	0.988	0.67	1.61	-	3	0	0	100%	1
8XAM_SAM_B_402	100%	44%	0.041	0.984	0.88	1.26	-	3	0	0	100%	1
5LSA_SAM_A_303	100%	33%	0.046	0.986	0.91	1.73	-	4	2	0	100%	1
8QE3_SAM_A_402	99%	62%	0.047	0.984	0.6	0.84	-	2	0	0	100%	1
4IV0_SAM_B_302	99%	37%	0.051	0.986	1.1	1.37	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.